What is it about?
One of the main causes of lifelong blindness in patients with advanced diabetic retinopathy or serious eye injuries is retinal fibrosis, a condition where scar tissue develops in the back of the eye. Patients' only choice at this time is surgery because there are currently no approved drugs to treat or prevent this scarring. Our investigation revealed that a particular protein known as BMP2 (Bone Morphogenetic Protein-2) and its signaling pathway are a major biological cause of the problem. We discovered that BMP2 is a key factor in the retina's scar formation. Our findings point to BMP2 as a potential new therapeutic target to prevent retinal scarring and maintain vision by identifying it as the primary cause of the problem.
Featured Image
Photo by Ian Talmacs on Unsplash
Why is it important?
Finding a new treatment for retinal fibrosis is crucial because today's patients have only one option: invasive surgery. Unfortunately, surgery doesn't always succeed and can sometimes lead to further complications. Our research highlights a promising new approach—blocking the BMP2 pathway to prevent scar tissue from forming in the first place. Stopping this process early could prevent retinal detachment and save the vision of millions suffering from advanced eye diseases.
Perspectives
This article bridges two vital fields of medicine: eye health and scar tissue formation (fibrosis). For patients suffering from severe retinal injuries, permanent sight loss has long been a devastating outcome with few solutions. I am honored to highlight a potential new treatment strategy that goes beyond traditional surgery, demonstrating how targeting specific biological pathways can protect and restore human eyesight.
Mohamed Al-Shabrawey
Oakland University
Read the Original
This page is a summary of: Bone morphogenetic protein signaling as a key regulator of retinal fibrosis, Proceedings of the National Academy of Sciences, October 2026, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2603111123.
You can read the full text:
Contributors
The following have contributed to this page
